Thermo Fisher Scientific is to provide novel protein research products to the Institute for Systems Biology, supporting a two-year project to map the human proteome that is expected to accelerate biomarker discovery and advance personalized medicine.
26 May, 2010
Scientists at the Karolinska Institutet have developed a DNA vaccine that restricts the supply of blood to tumours and slows the growth of breast cancer tumours in mice.
25 May, 2010
Scientists have revealed that a set of proteins act as the cell’s ‘nose’ to ‘sniff out’ molecules that trigger cell growth.
24 May, 2010
Evotec has announced that a compound in its alliance with Boehringer Ingelheim has advanced into clinical trials. With the initiation of phase I studies, Evotec will receive a milestone payment of €2 million.
20 May, 2010
CCS Cell Culture Service, an international supplier of custom generated recombinant cell lines and custom frozen cells and membranes, has announced the opening of its Princeton, New Jersey, laboratory and office space.
14 May, 2010
London, UK, 11 May 2010 London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, is pleased to announce that the proceedings of its inaugural 2009 conference have been published in the May 2010 issue of Drug Discovery Today. The conference, ‘Harnessing Genetic Knowledge To Improve Clinical Development and Patient Care’, brought together pharma and biotech companies, academia and regulatory bodies to discuss the value that pharmacogenetics can bring to drug development.
11 May, 2010
New research funded by hearing loss charity RNID has revealed that even if hearing recovers after noise damage, permanent tinnitus could still develop.
11 May, 2010
Gentronix’s specialized GreenScreen HC test aims to enable pharmaceutical companies to accurately test compounds for genotoxicity without disrupting simultaneous drug discovery processes.
10 May, 2010
MDM2, the negative regulator of the tumour suppressor p53, is a major cancer target, and extensive evidence has shown that small molecules antagonizing this protein–protein interaction might have therapeutic value in fighting cancer.
06 May, 2010